RSV Research Study
Respiratory Syncytial Virus (RSV) is a common virus that can cause respiratory infections, especially in infants and young children. RSV is highly contagious and spreads easily through respiratory secretions like saliva and mucus. Symptoms of an RSV infection can include coughing, wheezing, and fever, and in severe cases, it can cause pneumonia or bronchitis. In most cases, RSV infections are mild and go away on their own within a week or two without any treatment. However, in some cases, RSV infections can be serious and require hospitalization. There is no cure for RSV, but there are medications and treatments that can help manage symptoms and prevent complications in people at high risk, such as premature infants or those with weakened immune systems.
Centricity Research is currently enrolling participants in an RSV vaccine study in our Columbus, GA location. Compensation may be available for time and travel for qualified participants.
-Ages 65 and older
-Tested positive for RSV, but not hospitalized
-Diagnosed with at least one of the following: congestive heart failure, asthma, or COPD
-New onset or worsening of these symptoms in the last 72 hours
-Other qualification criteria may apply
-Participation in the study is voluntary, and participants can withdraw at any time.
Study Duration: approximately 1 month (33 days)
Compensation for time and travel: Up to $877 for qualified participants
Location: Acute Care, 7901 Veterans Parkway, Columbus, GA, 31909
You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number EDP938-104
To Learn More, Call Us At 706-321-0495
or Click Here and Someone Will Contact You Shortly!